Health/Life Sciences – Page 32 of 54

Shares of Gates-backed Vir Bio tumble after $143M IPO to fund infectious disease efforts

It was a rough Wall Street debut for Vir Biotechnology, a San Francisco company with ambitious plans to battle infectious… Read More

Cadence Neuroscience raises $15M for epilepsy treatment created at Mayo Clinic

Medical device startup Cadence Neuroscience raised $15 million to develop a therapy for the treatment of epilepsy. The Series A… Read More

Fred Hutch scientist on how gold nanoparticles could bring CRISPR to the developing world

Genetically editing cells using CRISPR could be the answer to curing genetic disorders such as sickle cell anemia. But in… Read More

Insurance giant Humana invests $20M in healthcare tech company Accolade

Accolade, a Seattle-based company that operates a technology platform to help employees navigate healthcare, landed a $20 million investment from… Read More

Universal blood test from Microsoft and Adaptive is a Google-sized data challenge

A novel effort from Microsoft and Adaptive Biotechnologies to diagnose multiple diseases from a single blood test is a data… Read More

Bill Gates lays out his predictions for global health during tribute to Stephen Hawking

What’s the shape of global health to come? Microsoft co-founder Bill Gates issued two hopeful predictions for the year 2040… Read More

Univ. of Washington gets $50M gift to create brain health institute

The University of Washington is putting a $50 million philanthropic donation toward a new institute that will research and develop… Read More

Univ. of Washington spinout Icosavax raises $51M to fight viruses with computer-designed vaccines

Seattle-based biotech startup Icosavax today scored $51 million in funding to create vaccines from artificial viruses. The Series A financing… Read More

Fred Hutch spinout SEngine raises $5.1M to test cancer treatment drugs against a patient’s tumors

Seattle startup SEngine Precision Medicine has raised $5.1 million in fresh funding as it looks to commercialize a platform that… Read More

Seattle nonprofit Sage Bionetworks joins $37M national effort to hunt for Alzheimer’s drugs

Seattle-based nonprofit Sage Bionetworks is leading a heavily funded national effort to find new drugs to fight Alzheimer’s, a disease… Read More

Microsoft will use AI to supercharge Novartis’ giant drug-development engine

Microsoft has reached a deal with pharmaceutical giant Novartis that aims to bring the power of artificial intelligence to drug… Read More

98point6 brings AI-fueled telemedicine to Sam’s Club members

Sam’s Club members in three states will soon be able to see a physician right from their phones at any… Read More

Stem cell startup Silene Biotech acquired by NanoSurface Biomedical in all-Seattle deal

NanoSurface Biomedical has snapped up Silene Biotech in a union of two Seattle startups that bets on the growing importance… Read More

Amazon launches on-demand healthcare clinic for Seattle-area employees

Healthcare is getting the Amazon treatment. The tech giant today launched Amazon Care, a primary care service for its employees… Read More

Adaptive and Illumina to make immune sequencing kits for labs, streamlining the detection of disease

Adaptive Biotechnologies signed a deal with Illumina, the largest genetic sequencing firm in the U.S., to produce kits that can… Read More

A-Alpha Bio raises $2.8M for genetically engineered drug discovery platform

A Seattle startup that took root at the University of Washington has closed a $2.8 million seed round for a… Read More

Are dogs conscious? How about computers? Brain scientist Christof Koch takes on deep questions

Do animals possess consciousness? Can consciousness be uploaded into a computer? Can we measure objectively whether someone is conscious or… Read More

Fred Hutch spinout Faraday Pharmaceuticals raises $25M for muscle loss prevention drug

When a patient is bedridden during a hospital stay, they can lose muscle mass at a rapid clip, compounding problems… Read More

How do drugs interact with supplements? Supp.AI search engine tracks down clues

Physicians and regulators keep close tabs on how different drugs interact. But what about interactions involving dietary supplements? “There’s just… Read More

University of Washington spinout Split Bio raises cash for RNA sequencing kits

University of Washington spinout Split Bio raised $560,000 in bridge financing to fund the manufacturing of kits that allow scientists… Read More

Fujifilm SonoSite and AI2 team up to add artificial intelligence to ultrasound imaging

A new collaboration between Fujifilm SonoSite and the Allen Institute for Artificial Intelligence aims to use AI to generate better interpretations of ultrasound… Read More

Fred Hutch President Gary Gilliland to step down as leader of cancer research powerhouse

Gary Gilliland, president and director of the Fred Hutchinson Cancer Research Center, announced plans to step down from his post… Read More

Navigating Cancer raises $26M, aims to change the patient experience for oncology care

Navigating Cancer, a Seattle startup that makes software to help providers and patients manage cancer treatment, landed $26 million in… Read More

Migraine drugmaker Alder Biopharmaceuticals to be acquired for nearly $2B by Lundbeck

Danish drugmaker Lundbeck is set to buy Bothell, Wash.-based Alder Biopharmaceuticals in a deal that could be worth up to… Read More

Y Combinator grad Brave Care raises another $5.2M for tech-fueled urgent care service for kids

Brave Care is attracting so much investor attention that it didn’t even need to pitch at Y Combinator Demo Day.… Read More

No poop required: Researchers devise blood test for gut microbiome diversity using data from defunct startup Arivale

If you want to know what’s going on in your gut microbiome, the community of bacteria in our intestines that… Read More

Why Nestlé just bought a personalized vitamin startup in Washington state

A small startup from the Pacific Northwest is now part of a global food and beverage behemoth. Nestlé Health Science… Read More

Genomics pioneer Lee Hood launches new institute to fight Alzheimer’s with data and wellness

If you want a glimpse at medicine’s track record against Alzheimer’s, look no further than the numbers: Pharmaceutical companies have… Read More

Alexandria doubles down on decades-long Seattle biotech bet with Mercer ‘Mega Block’ deal

As it closes in on one of the most valuable land deals in Seattle history, Alexandria Real Estate Equities is… Read More

Canadian biotech company Chinook Therapeutics raises $65M for rare kidney disease therapies

Chinook Therapeutics, a Vancouver, B.C.-based biotech company creating targeted therapies for kidney diseases, raised $65 million in a Series A… Read More